NIFTY 50▼23,995.35
-309.00 (-1.27%)
SENSEX▼78,782.24
-941.88 (-1.18%)
NIFTY BANK▼51,215.25
-458.65 (-0.89%)
TATA MOTORS▼824.10
-19.35 (-2.29%)
SUZLON ENERGY▼66.32
-1.82 (-2.67%)
TATA STEEL▼146.95
-2.80 (-1.87%)
INDIAN RAILWAY FINANCE CORP▼153.24
-4.87 (-3.08%)
TATA POWER▼429.05
-16.40 (-3.68%)
RAIL VIKAS NIGAM▼446.20
-24.75 (-5.26%)
RELIANCE INDUSTRIES▼1,302.15
-36.50 (-2.73%)
VODAFONE IDEA▼7.88
-0.57 (-6.75%)
ZOMATO▼245.08
-3.91 (-1.57%)
RELIANCE POWER▼42.03
-1.00 (-2.32%)
INDIAN RENEWABLE ENERGY▼205.38
-6.60 (-3.11%)
ADANI POWER▼585.00
-12.35 (-2.07%)
YES BANK▼20.33
-0.38 (-1.83%)
STATE BANK OF INDIA▲829.85
8.65 (1.05%)
NHPC▼83.30
-0.83 (-0.99%)
HDFC BANK▼1,714.10
-23.20 (-1.34%)
OLA ELECTRIC MOBILITY LTD▼80.84
-2.00 (-2.41%)
JIO FIN SERVICES LTD▼319.85
-6.35 (-1.95%)
INDIAN OIL CORP▼138.93
-6.06 (-4.18%)
BHARAT ELECTRONICS▼284.15
-4.50 (-1.56%)
MRF▼1,20,876.75
-2453.55 (-1.99%)
GTL INFRA▼2.11
-0.07 (-3.21%)
ADANI PORT & SEZ▼1,349.25
-45.15 (-3.24%)
JAIPRAKASH POWER VENTURES▼17.88
-0.59 (-3.19%)
ITC▼484.60
-5.70 (-1.16%)
MERCURY LABORATORIES LIMITED Share Price
MERCURYLAB
₹916.75+₹46.80 (5.38%) TodayLast updated on 04 Nov, 2024 | 15:28 IST
MERCURY LABORATORIES LIMITED Share Price Chart
Please wait...
Company overview
MERCURY LABORATORIES LIMITED Financials
Market cap ₹111 Crs | Open ₹964.75 | Close ₹869.95 |
Circuit range ₹1,127.70 - ₹751.80 | Day range ₹915.25 - ₹964.75 | Year range ₹710.20 - ₹1,303.00 |
Volume 111 | Avg. traded ₹947.82 | Revenue (12m) ₹74 Crs |
MERCURY LABORATORIES LIMITEDMercury Laboratories Limited is an India-based pharmaceutical company. The Company operates through the Pharmaceuticals Products segment. It is engaged in the manufacturing and export of a range of pharmaceutical items. The products of the Company are in the segment of gynecology and pediatrics. Its products include antibiotic, antifungal, and antiviral formulations; anti-inflammatory formulations; antimalarial formulations; digestive formulations; hypoglycemic formulations; multivitamin formulations; central nervous system formulations; gynec formulations; CVS formulations; cough and cold formulations; and miscellaneous formulations, and innovative products. Its antibiotic, antifungal, and antiviral formulations include azithromycin tablets, azithromycin dispersible tablets, griseofulvin tablets, metronidazole tablets, and others. Its anti-inflammatory formulations include dexamethasone tablets, glucosamine sulphate tablets, dexamethasone sodium phosphate injection, and others.
MERCURY LABORATORIES LIMITED Key indicators
52 week high ₹1,303.00 | 52 week low ₹710.20 | P/E ratio 22.28 |
P/B ratio 2.3 | ROE 11.72% | ROCE 13.61% |
Dividend yield 0.36% | Debt/Equity ratio 0.11 | EPS 47.12 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
MERCURY LABORATORIES LIMITED Fundamentals
MERCURY LABORATORIES LIMITED Financial Ratios
Operating profit margin13.39% | Net profit margin7.48% |
ROE11.72% | ROA8.56% |
ROCE13.61% |
Learn more
MERCURY LABORATORIES LIMITED Share Price history
Day | Open | Close | Change % |
---|---|---|---|
Mon, Nov 4 2024 | ₹964.75 | ₹939.75 | |
Fri, Nov 1 2024 | ₹964.75 | ₹869.95 | -6.18% |
Thu, Oct 31 2024 | ₹952.00 | ₹927.30 | -1.27% |
Wed, Oct 30 2024 | ₹952.00 | ₹939.25 | |
Tue, Oct 29 2024 | ₹958.00 | ₹926.30 | -2.70% |
Mon, Oct 28 2024 | ₹952.00 | ₹952.00 | |
Fri, Oct 25 2024 | ₹925.00 | ₹934.80 | -0.75% |
Thu, Oct 24 2024 | ₹980.00 | ₹941.85 | -1.80% |
Events
Corporate actions
Dividend • ₹3.5/share
Ex date 20 Sep 2024
Dividend • ₹3.5/share
Ex date 20 Sep 2023
Dividend • ₹3.5/share
Ex date 19 Sep 2022
Learn more
More